Form 8-K - Current report:
SEC Accession No. 0001144204-17-042631
Filing Date
2017-08-14
Accepted
2017-08-14 08:00:43
Documents
3
Period of Report
2017-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v473068_8k.htm 8-K 20993
2 EXHIBIT 99.1 v473068_ex99-1.htm EX-99.1 82180
3 GRAPHIC image_001.jpg GRAPHIC 6767
  Complete submission text file 0001144204-17-042631.txt   113762
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 171027251
SIC: 2834 Pharmaceutical Preparations